Tag: Moderna Inc
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation...
mRNA-1283 induced a more robust immune response compared to Spikevax® COVID-19 vaccine, mRNA-1273.222
Next-generation mRNA vaccine design offers...
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions...
The Company's ESG strategy demonstrates its efforts to advance global health and environmental sustainability, as well as its commitments to...
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV)...
Moderna has submitted marketing authorization applications for the investigational RSV vaccine, mRNA-1345, with the European Medicines Agency, Swissmedic, and the Therapeutic Goods...
Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations...
The Enterprise Solutions Hub in the Philippines will support the Asia Pacific region and complements Moderna's Enterprise Solutions Hubs in Warsaw, Poland,...
Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in...
Announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Argentina, Canada, Israel, the US, and Taiwan for active immunization to...
Therapeutic Goods Administration of Australia Authorizes Moderna’s Covid-19 Vaccine in Children...
Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in...
Moderna Announces Plan to Expand Footprint in Asia with Four Additional...
Announcement reinforces Moderna's commitment to Asia and vision as a global commercial enterpriseNew subsidiaries to be established in Malaysia, Taiwan, Singapore, and...
